Jian Wang

Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy

Kaiyuan Wang, Jian Wang, Feng Wei et al. · Frontiers in Immunology · 2017 · 70 citations · Full text

FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non–small Cell Lung Cancer, A Collaborative Project Orbis Review

Paz J. Vellanki, Flora Mulkey, Adnan A. Jaigirdar et al. · Clinical Cancer Research · 2021 · 54 citations · Full text

CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy

Xue Bai, Ze-Qin Guo, Yan-Pei Zhang et al. · Nature Communications · 2023 · 51 citations · Full text

Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012

Jonathan Kay, Brian G. Feagan, Micheal Guirguis et al. · Biologicals · 2012 · 21 citations · Full text

Health Canada/biotecanada Summit, Preclinical Therapeutics, Regulatory Approval +14

PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy

Yan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai et al. · Cancer Cell · 2025 · 18 citations